How is Door Syndrome diagnosed?

Door Syndrome is a rare genetic disorder characterized by deafness, onychodystrophy (nail abnormalities), osteodystrophy (bone abnormalities), and intellectual disability (the acronym DOOR). Diagnosis is primarily confirmed through clinical evaluation of these specific physical features combined with molecular genetic testing to identify mutations in the TBC1D24 gene.

How is Door Syndrome diagnosed?

The diagnostic process for Door Syndrome typically begins with a physical examination by a pediatrician or clinical geneticist who identifies the hallmark clinical features. Because Door Syndrome is exceptionally rare, many families endure a prolonged "diagnostic odyssey," often visiting multiple specialists before a genetic cause is suspected. Definitive diagnosis is achieved via targeted gene panel testing or whole-exome sequencing to detect pathogenic variants in TBC1D24.

What tests are used to confirm Door Syndrome?

Clinicians utilize a multidisciplinary approach to verify the clinical presentation of Door Syndrome. Key assessments include:

• Genetic Testing: Sequencing the TBC1D24 gene to confirm the molecular diagnosis.


• Audiological Evaluation: Comprehensive hearing tests to assess the severity of sensorineural deafness.


• Skeletal Imaging: X-rays to identify hypoplastic or absent nails and phalanges (osteodystrophy).


• Neurological Assessment: EEG monitoring, as many patients with Door Syndrome experience seizures or intellectual disability.

Which specialists are involved in the diagnosis?

Due to the multisystem nature of Door Syndrome, a team approach is essential. A clinical geneticist is usually the lead in confirming the diagnosis, supported by neurologists, audiologists, and orthopedic specialists. If your local physicians are unfamiliar with Door Syndrome, it is vital to seek a referral to a major academic medical center or a center specializing in rare genetic disorders.

What conditions are similar to Door Syndrome?

Door Syndrome can be clinically confused with other syndromes presenting with deafness and skeletal anomalies, such as Coffin-Siris syndrome or various distal arthrogryposis disorders. Distinguishing Door Syndrome from these mimics relies heavily on the specific pattern of nail and bone involvement, which is why accurate genetic testing is the gold standard for reaching a final diagnosis.

Next steps

• Consult with a board-certified clinical geneticist to discuss TBC1D24 sequencing.


• Connect with the 13 members currently sharing their experiences with Door Syndrome on DiseaseMaps.org.


• Request a referral to a multidisciplinary rare disease clinic to coordinate specialized care.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Online Mendelian Inheritance in Man (OMIM) entry #220500


• Orphanet: Database for rare diseases and orphan drugs